Form 4: Pulmonx General Counsel Sells Shares for Tax Obligations
Insider Transaction Report
Pulmonx Corp's General Counsel, David Aaron Lehman, sold 10,278 shares of common stock to cover tax withholding obligations related to RSU vesting.
Summary
- David Aaron Lehman, General Counsel of Pulmonx Corp (LUNG), reported the sale of 10,278 shares of common stock.
- The sales occurred on December 1, 2025, at a price of $1.57 per share.
- These transactions were executed to satisfy tax withholding obligations arising from the vesting of Restricted Stock Units (RSUs) granted on March 1, 2022, March 1, 2023, March 1, 2024, and March 3, 2025.
- Following these transactions, Lehman directly beneficially owns 252,992 shares of common stock.
Sentiment
Score: 5
Explanation: The transaction is a non-discretionary sale to cover tax obligations upon RSU vesting, which is a routine event and generally considered neutral in terms of insider sentiment.
Future Outlook
NA
Industry Context
This Form 4 filing details a routine insider transaction for tax purposes and does not provide information relevant to broader industry trends or competitive analysis.
Stakeholder Impact
- The sale of shares for tax withholding purposes by an officer is a routine event with minimal direct impact on shareholders, employees, customers, suppliers, or creditors. It reflects standard compensation practices and tax obligations.
Key Dates
| Date | Description |
|---|---|
| March 1, 2022 | Grant date of Restricted Stock Units (RSUs) for which shares were sold to cover tax withholding. |
| March 1, 2023 | Grant date of Restricted Stock Units (RSUs) for which shares were sold to cover tax withholding. |
| March 1, 2024 | Grant date of Restricted Stock Units (RSUs) for which shares were sold to cover tax withholding. |
| March 3, 2025 | Grant date of Restricted Stock Units (RSUs) for which shares were sold to cover tax withholding. |
| December 1, 2025 | Transaction date for the sale of common stock to cover tax withholding obligations. |
| December 2, 2025 | Signature date of the reporting person for the Form 4 filing. |
Recommendation
holdThis Form 4 reports a non-discretionary sale of shares by an officer to cover tax withholding obligations related to RSU vesting. Such transactions are routine and do not typically signal a change in the insider's view of the company's prospects or warrant a change in investment recommendation based solely on this filing. Investors should 'hold' and look for more substantive operational or financial news.
Keywords
Pulmonx, LUNG, SEC Form 4, Insider Trading, Stock Sale, Restricted Stock Units, Tax Withholding, David Aaron Lehman, General Counsel
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.